G. Guarnaccia, J. Massenet, A. Cecchini, E. Guarnaccia, B. Silvestri, C. Nicoletti, J. R. Barajas, D. Sala, M. Garcia Teneche, B. Li, L. Caputo, C. Stamenkovic, T. M. Moreno, R. Murad, S. Delaware, D. Mayer, Y. Zhang, P. Gupta, A. R. Colas, A. Vasciaveo, C. Kumsta, P. D. Adams, Y. X. Wang, C. Gargioli, C. Commisso, P. L. Puri, A. Sacco
Cancer cachexia limits treatment tolerance and survival in pancreatic ductal adenocarcinoma (PDAC), yet the tumor-derived signals driving tissue dysfunction remain poorly understood. Here, we identify serum amyloid A1 (SAA1) as a mediator of tumor-to-host communication acting through Toll-like receptor 4 (TLR4). Tumor-derived SAA1 was elevated in human PDAC and in a mouse PDAC model and disrupted both myofiber and muscle stem cell (MuSC) homeostasis. Genetic reduction of tumor-derived SAA1 uncoupled tumor progression from host wasting, preserving muscle mass and function and prolonging survival without affecting primary tumor growth. Mechanistically, SAA1-TLR4 signaling drove multicellular remodeling of the skeletal muscle microenvironment. Therapeutic TLR4 inhibition after cachexia onset restored muscle mass, function and MuSC abundance and prolonged survival independently of tumor growth. Conservation of SAA1-TLR4 signaling in human skeletal muscle identifies a therapeutically actionable tumor-host pathway and demonstrates that host deterioration can be targeted independently of tumor progression.